retatrutide clinical data retatrutide Reta trial & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP what is retatrutide peptide used

N Engl J Med 2022;387:20516.ArticlePubMed 19

A: This must be discussed with your doctor

This can help prolong the feeling of fullness after eating and steadies the release of glucose (and other nutrients) into the bloodstream, supporting both weight management and blood sugar stability

However, competitive pressure from Novo Nordisk's pipeline and the expansion of Medicare negotiated pricing may limit how much of a premium Lilly can charge

Jaisinghani thinks that having the pill will give patients more options and may also reduce the stigma often associated with taking medication for weight loss

That's not an accident